First batch recall for therapeutic cannabis trials
Just over a week after the launch of medical cannabis trials, This first batch recall follows a number of incidents reported to the French National Agency for the Safety of Medicines (ANSM).
According to our information, the product in question, distributed by French laboratory Medipha, is the oral solution (10% THC / 10% CBD) from Canadian producer Tilray, a full-spectrum oil containing 10 mg/mL THC and 10 mg/mL CBD, which is said to be leaking from the bottle cap.
The recall will take place shortly, and the drug can no longer be prescribed for the time being. To avoid any further delay in the start of the trial, the batch's secondary supplier - Australian cannabis producer Little Green Pharma in partnership with French pharmaceutical company Intsel Chimos - is set to take over.
The same product had already suffered recalls as part of Germany's medical cannabis program, this time due to too low a THC content compared to what was labeled.
When contacted, Tilray did not respond to our request.
-
Business3 weeks ago
New York Opens Its Farmers' Markets to Small-Scale Cannabis Producers
-
Cannabis in France4 weeks ago
French Polynesia Is Finally Ready to Launch Its «Medical Cannabis» Pilot Program After Months of Delays
-
Cannabis in Nepal4 weeks ago
A Nepalese province legalizes medical cannabis
-
Cannabis in California4 weeks ago
Eight years after legalization, cannabis use in California has not increased
-
Cannabis in India3 weeks ago
India Approves a Synthetic CBD Drug for Anxiety
-
Cannabis in Africa3 weeks ago
Rwanda: A New License Revives the Country's Ambitions in Medical Cannabis
-
Cannabis in Europe3 weeks ago
The EU Simplifies Regulations Governing Hemp Cultivation
-
Cannabis in Canada4 weeks ago
Quick Hit July 2026: What We Missed in Recent Weeks


You must be logged in to post a comment Login